19-10354011-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003331.5(TYK2):​c.2908+31T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.535 in 1,610,030 control chromosomes in the GnomAD database, including 232,452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 23886 hom., cov: 33)
Exomes 𝑓: 0.53 ( 208566 hom. )

Consequence

TYK2
NM_003331.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.76

Publications

22 publications found
Variant links:
Genes affected
TYK2 (HGNC:12440): (tyrosine kinase 2) This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also a component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with Immunodeficiency 35. [provided by RefSeq, Sep 2020]
TYK2 Gene-Disease associations (from GenCC):
  • immunodeficiency 35
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-10354011-A-G is Benign according to our data. Variant chr19-10354011-A-G is described in ClinVar as Benign. ClinVar VariationId is 673300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYK2NM_003331.5 linkc.2908+31T>C intron_variant Intron 20 of 24 ENST00000525621.6 NP_003322.3 P29597A0A024R7E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYK2ENST00000525621.6 linkc.2908+31T>C intron_variant Intron 20 of 24 1 NM_003331.5 ENSP00000431885.1 P29597

Frequencies

GnomAD3 genomes
AF:
0.556
AC:
84405
AN:
151810
Hom.:
23842
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.639
Gnomad AMI
AF:
0.590
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.563
Gnomad EAS
AF:
0.636
Gnomad SAS
AF:
0.542
Gnomad FIN
AF:
0.532
Gnomad MID
AF:
0.586
Gnomad NFE
AF:
0.520
Gnomad OTH
AF:
0.530
GnomAD2 exomes
AF:
0.527
AC:
131111
AN:
248602
AF XY:
0.527
show subpopulations
Gnomad AFR exome
AF:
0.640
Gnomad AMR exome
AF:
0.398
Gnomad ASJ exome
AF:
0.551
Gnomad EAS exome
AF:
0.651
Gnomad FIN exome
AF:
0.537
Gnomad NFE exome
AF:
0.528
Gnomad OTH exome
AF:
0.525
GnomAD4 exome
AF:
0.533
AC:
776476
AN:
1458102
Hom.:
208566
Cov.:
33
AF XY:
0.531
AC XY:
385216
AN XY:
725498
show subpopulations
African (AFR)
AF:
0.648
AC:
21661
AN:
33428
American (AMR)
AF:
0.410
AC:
18340
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.548
AC:
14295
AN:
26106
East Asian (EAS)
AF:
0.570
AC:
22599
AN:
39662
South Asian (SAS)
AF:
0.519
AC:
44688
AN:
86168
European-Finnish (FIN)
AF:
0.540
AC:
28401
AN:
52620
Middle Eastern (MID)
AF:
0.569
AC:
3223
AN:
5666
European-Non Finnish (NFE)
AF:
0.532
AC:
589984
AN:
1109476
Other (OTH)
AF:
0.552
AC:
33285
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
19060
38120
57179
76239
95299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16934
33868
50802
67736
84670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.556
AC:
84508
AN:
151928
Hom.:
23886
Cov.:
33
AF XY:
0.554
AC XY:
41162
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.640
AC:
26521
AN:
41452
American (AMR)
AF:
0.485
AC:
7381
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
1952
AN:
3466
East Asian (EAS)
AF:
0.636
AC:
3272
AN:
5146
South Asian (SAS)
AF:
0.541
AC:
2608
AN:
4824
European-Finnish (FIN)
AF:
0.532
AC:
5627
AN:
10576
Middle Eastern (MID)
AF:
0.592
AC:
173
AN:
292
European-Non Finnish (NFE)
AF:
0.520
AC:
35319
AN:
67924
Other (OTH)
AF:
0.531
AC:
1118
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1937
3875
5812
7750
9687
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
722
1444
2166
2888
3610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.489
Hom.:
3951
Bravo
AF:
0.558
Asia WGS
AF:
0.585
AC:
2030
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 77% of patients studied by a panel of primary immunodeficiencies. Number of patients: 74. Only high quality variants are reported. -

Immunodeficiency 35 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.35
DANN
Benign
0.27
PhyloP100
-1.8
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs280497; hg19: chr19-10464687; COSMIC: COSV53385733; COSMIC: COSV53385733; API